Botanical species · safety record

Astragalus membranaceus

The EFSA Compendium of Botanicals holds 4 constituent measurements for Astragalus membranaceus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Astragalus membranaceus (Fisch.) Bunge

4Constituent measurements

0Safety records

2Cited sources

2,798Licensed products (Canada)

Also recorded as

Astragalus membranaceus var. mongholicus (Bunge) P.K.Hsiao

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 2,798 licensed products naming Astragalus membranaceus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA
Fresh
decoction
fluid

Source material stated

Astragalus membranaceus - root
Astragulus membranaceus
Dried root (honey-roasted)
Dried root(s)
Fruit
Leaf
Mushroom
New material

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Astragaloside i	Roots and other underground parts	Solvent extraction	1.64 Percent	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Astragaloside ii	Roots and other underground parts	Solvent extraction	1.12 Percent	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Astragaloside iii	Roots and other underground parts	Solvent extraction	1.08 Percent	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Saponins	Roots and other underground parts	Solvent extraction	—	Unspecified	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Ionkova, I., Momekov, G., Proksch, P. Effects of cycloartane saponins from hairy roots of Astragalus membranaceus Bge., on human tumor cell targets. FITOTERAPIA, 2010, vol. 81, no. 5, p. 447-451. DOI
Tin, Mandy M. Y., Cho, Chi-Hin., Chan, Kelvin., James, Anthony E., Ko, Joshua K. S. Astragalus saponins induce growth inhibition and apoptosis in human colon cancer cells and tumor xenograft . Carcinogenesis, 2007, vol. 28, no. 6, p. 1347-1355. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature